T oxin-antitoxin (TA) systems were first identified to be addictive genetic elements responsible for the maintenance of plasmid stability during cell segregation (1, 2). Subsequently, chromosomally encoded TA systems were characterized to be involved in several mechanisms of toxin action (3, 4). TA systems typically consist of two elements, a toxin protein that suppresses cell growth by targeting essential cellular metabolic pathways and an antitoxin RNA or protein that binds to and blocks the growth inhibition activity of the toxin. Different types of TA systems have been defined according to the nature and modes of action of antitoxins, and of these, the type II TA systems are the most abundant and well studied (5, 6). The type II toxins-antitoxins are typically encoded in the same operon, where the gene for the antitoxin is located upstream of that for the toxin, except in the case of higBA, which has a reversed gene order (7). The type II antitoxin is a protein that directly interacts with its cognate toxin, resulting in neutralization of toxicity. The antitoxin or the toxin-antitoxin protein complex often acts as a repressor that autoregulates the transcription of TA operons via its ability to bind to the promoter (8). During cellular stress, the antitoxin is hydrolyzed by a protease, such as Lon or Clp, to release the toxin from the protein complex and derepress transcription of the TA operon (7). These properties allow TA systems to play regulatory roles in bacterial gene expression and the establishment and maintenance of dormancy. This nonreplicative state may contribute to latency.Type II TA systems are classified into several different families on the basis of sequence similarities and the functions of the toxins (7-9). CcdB and ParE inhibit DNA replication by targeting DNA gyrase (10, 11). Doc arrests translation elongation by phosphorylation of elongation factor Tu (12, 13). Kis and HicA cleave mRNA in a ribosome-independent manner (14, 15). MazF targets various RNAs, including mRNA, 16S rRNA,. RelE inhibits translation by cleavage of ribosome-bound mRNAs at the ribosomal A site (20). HipA inhibits translation by phosphoryla-